Latest viral hepatitis mapping report released
And the Winners Are...
And the Winners Are… We are thrilled to announce the winners of this year's World…Read Article
Small grants now available to screen hepatitis B short film
Hepatitis Queensland has launched a small grants program to support Aboriginal and Torres Strait Islander…Read Article
National Condom Day: Practicing Safe Sex is Essential for Everyone
Hepatitis Queensland is proud to support National Condom Day. Celebrated annually on February 14th, National…Read Article
The full report provides updated estimates broken down by geographic area including state, territory, PHN and Statistical Area 3 level and identifies priority areas for response.
This year the report contains newly revised region-specific estimates of chronic hepatitis B (CHB) prevalence in Aboriginal and Torres Strait Islander Australians, and adjusted chronic hepatitis C (CHC) prevalence and treatment uptake to account for people currently in correctional facilities. Also new this year is the inclusion of liver cancer incidence data with comparisons to CHB and CHC prevalence and other risk factors at a PHN level.
This report forms the baseline for assessing Australia’s progress towards meeting the targets set out in the Third National Hepatitis B Strategy and Fifth National Hepatitis C Strategy, which cover the period 2018-2022 and set out clear indicators for progress towards eliminating the impact of viral hepatitis.